AF increases UBA1 activity at concentrations roughly 4.5 to 73 times lower than the maximum serum concentration (Cmax, 459.8 nM) achieved by the approved therapeutic dose for rheumatoid arthritis33. This evidence concerns the gene UBA1 and atrial fibrillation.